Infection prevention and control and preparedness for COVID-19 in healthcare settings - fourth update
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.
Consultation on Plasmodium vivax transmission risk, Stockholm, 17–18 January 2012
In response to the malaria outbreak in Greece in 2011, ECDC organised an expert consultation on Plasmodium vivax transmission in Europe on 17 and 18 January 2012. The overall objective of this consultation was to gain a comprehensive understanding of the malaria transmission potential in Greece and in Europe in order to propose recommendations for actions for preparedness and response at the EU and country levels.
Novel coronavirus (SARS-CoV-2) - Discharge criteria for confirmed COVID-19 cases
This document suggests criteria to be considered when deciding whether a confirmed COVID-19 case can be safely (i.e. without being infectious) discharged from hospital or released from home isolation.
Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
Candida auris: Epidemiological situation, laboratory capacity and preparedness in European Union and European economic area countries, 2013 to 2017
Kohlenberg, A., Struelens, M.J., Monnet, D.L., Plachouras, D., Apfalter, P., Lass-Flörl, C., Muchl, R., Presterl, E., Willinger, B., Catry, B., Philipova, I., Budimir, A., Hadjihannas, L., Arendrup, M.C., Märtin, P., Jalava, J., Berger-Carbonne, A., Dromer, F., Kurzai, O., Vrioni, G., Kontopidou, F., Kiss, K., Kurcz, A., Ásmundsdóttir, L.R., Burns, K., Moro, M.L., Dimina, E., Valinteliene, R., Perrin, M., Barbara, C., de Greeff, S., Kacelnik, O., Deptula, A., Rodrigues, M.R., Serban, R., Schréterová, E., Stefkovicova, M., Serdt, M., Alastruey-Izquierdo, A., Pemán, J., Byfors, S., Chryssanthou, E., Borman, A., Brown, C., Guy, R., Johnson, E., Reilly, J.
Conducting in-action and after-action reviews of the public health response to COVID-19
This document aims to support the implementation of after-action reviews (AARs) and in-action reviews (IARs) focused on the public health response to COVID-19.
Checklist for hospitals preparing for the reception and care of coronavirus 2019 (COVID-19) patients
This document supports the public health preparedness planning for hospitals with regard to novel coronavirus disease 2019 (COVID-19).
This checklist is based on the current knowledge of the COVID-19 outbreak and the evidence available.
ECDC will update this checklist should new relevant information become available.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in Spain
The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
ECDC tool for the prioritisation of infectious disease threats
This qualitative tool, implemented as an Excel workbook, ranks infectious disease threats in a transparent, comparable and methodologically reproducible manner.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in the Netherlands
The present report is concerned with the emerging infection of tick-borne encephalitis in the Netherlands — the two first endemic cases occurring in July 2016 — in the larger context of a widespread and increasing incidence of lyme borreliosis.